REPORT ID 6629

Asia-Pacific Asthma Drugs Market Report 2017

Publish Date
26-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the Asia-Pacific Asthma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Asthma Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Asthma Drugs market competition by top manufacturers/players, with Asthma Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Sanofi
    Roche & Novartis
    Teva
    Merck
    AstraZeneca
    Boehringer Ingelheim
    ...

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Long-term Control Medications
    Quick-relief Medications (Rescue Medications)
    Medications for Allergy-induced Asthma

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Asthma Drugs Market Report 2017
1 Asthma Drugs Overview
    1.1 Product Overview and Scope of Asthma Drugs
    1.2 Classification of Asthma Drugs by Product Category
        1.2.1 Asia-Pacific Asthma Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Asthma Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Long-term Control Medications
        1.2.4 Quick-relief Medications (Rescue Medications)
        1.2.5 Medications for Allergy-induced Asthma
    1.3 Asia-Pacific Asthma Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Asthma Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Asia-Pacific Asthma Drugs Market by Region
        1.4.1 Asia-Pacific Asthma Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Asthma Drugs (2012-2022)
        1.5.1 Asia-Pacific Asthma Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Asthma Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Asthma Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Asthma Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Asthma Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Asthma Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Asthma Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Asthma Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Asthma Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Asthma Drugs (Volume) by Application
    2.4 Asia-Pacific Asthma Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Asthma Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Asthma Drugs Revenue and Market Share by Region (2012-2017)

3 China Asthma Drugs (Volume, Value and Sales Price)
    3.1 China Asthma Drugs Sales and Value (2012-2017)
        3.1.1 China Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Asthma Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China Asthma Drugs Sales Price Trend (2012-2017)
    3.2 China Asthma Drugs Sales Volume and Market Share by Type
    3.3 China Asthma Drugs Sales Volume and Market Share by Application

4 Japan Asthma Drugs (Volume, Value and Sales Price)
    4.1 Japan Asthma Drugs Sales and Value (2012-2017)
        4.1.1 Japan Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Asthma Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Asthma Drugs Sales Price Trend (2012-2017)
    4.2 Japan Asthma Drugs Sales Volume and Market Share by Type
    4.3 Japan Asthma Drugs Sales Volume and Market Share by Application

5 South Korea Asthma Drugs (Volume, Value and Sales Price)
    5.1 South Korea Asthma Drugs Sales and Value (2012-2017)
        5.1.1 South Korea Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Asthma Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Asthma Drugs Sales Price Trend (2012-2017)
    5.2 South Korea Asthma Drugs Sales Volume and Market Share by Type
    5.3 South Korea Asthma Drugs Sales Volume and Market Share by Application

6 Taiwan Asthma Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Asthma Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Asthma Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Asthma Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan Asthma Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Asthma Drugs Sales Volume and Market Share by Application

7 India Asthma Drugs (Volume, Value and Sales Price)
    7.1 India Asthma Drugs Sales and Value (2012-2017)
        7.1.1 India Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Asthma Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India Asthma Drugs Sales Price Trend (2012-2017)
    7.2 India Asthma Drugs Sales Volume and Market Share by Type
    7.3 India Asthma Drugs Sales Volume and Market Share by Application

8 Southeast Asia Asthma Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Asthma Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Asthma Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Asthma Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia Asthma Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Asthma Drugs Sales Volume and Market Share by Application

9 Australia Asthma Drugs (Volume, Value and Sales Price)
    9.1 Australia Asthma Drugs Sales and Value (2012-2017)
        9.1.1 Australia Asthma Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Asthma Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Asthma Drugs Sales Price Trend (2012-2017)
    9.2 Australia Asthma Drugs Sales Volume and Market Share by Type
    9.3 Australia Asthma Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Asthma Drugs Players/Suppliers Profiles and Sales Data
    10.1 GlaxoSmithKline
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Asthma Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 GlaxoSmithKline Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Sanofi
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Asthma Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Sanofi Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Roche & Novartis
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Asthma Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Roche & Novartis Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Teva
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Asthma Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Teva Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Merck
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Asthma Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Merck Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 AstraZeneca
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Asthma Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 AstraZeneca Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Boehringer Ingelheim
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Asthma Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    ...

11 Asthma Drugs Manufacturing Cost Analysis
    11.1 Asthma Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Asthma Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Asthma Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Asthma Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Asthma Drugs Market Forecast (2017-2022)
    15.1 Asia-Pacific Asthma Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Asthma Drugs Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Asthma Drugs Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Asthma Drugs Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Asthma Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Asthma Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Asthma Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Asthma Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Asthma Drugs Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Asthma Drugs Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Asthma Drugs Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Asthma Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer